Table 3 Doses of sufentanil, ephedrine, and nicardipine and recovery time
Group TAP n = 30 | Group Control N = 31 | P-value | |
|---|---|---|---|
Opium consumption | |||
Intraoperative superaddition of sufentanil (μg) | 4.3 ± 1.5 | 10.2 ± 2.8 | < 0.001 |
Postoperative morphine consumption (mg) | 46.6 ± 8.4 | 66.8 ± 10.9 | < 0.001 |
Patients requiring ephedrine, n (%) | 2, (6.7%) | 1, (3.2%) | 0.976 |
Time to first flatus (h) | 77.6 ± 10.4 | 81.6 ± 10.4 | 0.131 |
PACU stay, (min) | 44.2 ± 7.9 | 54.5 ± 8.2 | < 0.001 |
Incidence of opium-related side effects, n(%) | |||
Sedation | 8, (26.7%) | 16, (51.6%) | 0.046 |
Nausea | 5, (16.7%) | 6, (19.4%) | 0.785 |
Vomiting | 0, (0%) | 1, (3.2%) | 0.987 |
Long hospitalization, n(%) | 5, (16.7%) | 13, (41.9%) | 0.031 |